PolyPid Ltd. - Ordinary Shares (PYPD)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 11% below Graham Number — thin margin of safety
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -311.4%
PolyPid Ltd. - Ordinary Shares (PYPD) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $86 million . Key value metrics: P/E ratio 2.3, P/B ratio 7.83, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
PolyPid Ltd. - Ordinary Shares — Fundamental Analysis Summary
PolyPid Ltd. - Ordinary Shares (PYPD) is trading 11% below its Graham Number of $5.32, offering a thin margin of safety. The stock carries a low trailing P/E ratio of 2.3x.
On financial health, PYPD shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -311.4% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.06.
StockPik's composite Value Score for PYPD is 33/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PYPD shows earnings declining at 18%.